DS Stage II Plasma Cell Myeloma Recruiting Phase 2 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0030429 (DS Stage II Plasma Cell Myeloma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01028716Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment